Skip to main content

Table 3 Effects of positive inotropic drugs on model parameters when administered before and after global ischemia.

From: Ischemia reperfusion dysfunction changes model-estimated kinetics of myofilament interaction due to inotropic drugs in isolated hearts

Before Ischemia

After Ischemia

Con

Dbt

Dop

Dig

Lev

Con

Dbt

Dop

Dig

Lev

Second order rate constants

Second order rate constants

α 1 (1/μM•s)

α 1 (1/μM•s)

4.5 ± 0.3

2.2 ± 0.2*

2.3 ± 0.3*

4.2 ± 0.3

4.4 ± 0.5

0.5 ± 0.1†

0.5 ± 0.2†

1.2 ± 0.2#

1.1 ± 0.2#†

1.6 ± 0.4#†

α a (1/μM•s)

α a (1/μM•s)

5.0 ± 0.2

8.0 ± 0.8*

14 ± 3*

5.8 ± 0.5

5.2 ± 0.3

1.7 ± 0.4†

4 ± 1#†

3.8 ± 0.6#†

4.2 ± 0.7#

2.4 ± 0.4†

β 1 (1/μM•s)

β 1 (1/μM•s)

0.12 ± 0.07

0.18 ± 0.15

2.2 ± 0.8*

0.2 ± 0.1

1.8 ± 0.9

10 ± 3†

4 ± 1#†

9.0 ± 0.5†

10 ± 2†

5.7 ± 2.0#†

β a (1/μM•s)

β a (1/μM•s)

118 ± 12

83 ± 9

29 ± 13*

110 ± 10

56 ± 9*

5.2 ± 0.7†

10 ± 2#†

11 ± 3#†

13 ± 4#†

15 ± 8#†

K 2 (1/μM•s)

K 2 (1/μM•s)

418 ± 14

775 ± 82*

355 ± 68

485 ± 59

351 ± 62

151 ± 63†

275 ± 41†

262 ± 76

249 ± 28†

250 ± 9#†

First order rate constants

First order rate constants

K 3 (1/s)

K 3 (1/s)

429 ± 24

348 ± 46

174 ± 42*

434 ± 31

508 ± 63

271 ± 39†

270 ± 43

517 ± 26#†

480 ± 24#

178 ± 19#†

K 4 (1/s)

K 4 (1/s)

18 ± 4

80 ± 17*

52 ± 9*

28 ± 9

37 ± 7*

60 ± 8†

90 ± 10#

65 ± 11

69 ± 6†

67 ± 13†

K d (1/s)

K d (1/s)

484 ± 21

872 ± 29*

656 ± 54*

500 ± 20

593 ± 71

87 ± 13†

331 ± 27#†

183 ± 30#†

227 ± 77#†

325 ± 47#†

K d '(1/s)

K d '(1/s)

765 ± 81

977 ± 32*

1218 ± 11*

728 ± 88

751 ± 64

377 ± 25†

375 ± 15†

378 ± 1†

450 ± 72†

398 ± 27†

  1. Values are expressed as mean ± SE. Con = Control, Dbt = Dobutamine, Dop = Dopamine, Dig = Digoxin, Lev = Levosimendan. Statistical significance was measured at *p < 0.05 vs. Control before ischemia, #p < 0.05 vs. Control after ischemia, †p < 0.05 after vs. before ischemia in the presence or absence of drugs.